- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05671302
Walk Together: A Family-Based Intervention for Hypertension In African Americans
April 5, 2024 updated by: Sarah Woods, University of Texas Southwestern Medical Center
The goal of this study is to determine the feasibility and acceptability of a novel family-based hypertension self-management intervention, Walk Together, adapted from an existing empirically-supported dyadic intervention, for implementation in primary care.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Hypertension is the driving risk factor for disparities in mortality and life expectancy between African Americans and Whites.
Hypertension self-management (including blood pressure monitoring, diet, exercise, and other lifestyle changes) is critical for improving hypertension control, and prior interventions have emphasized promoting patient-level behavior change to improve self-management adherence.
Though family members make substantial contributions to hypertension self-management for African Americans, family support is consistently underutilized by current hypertension self-management interventions.
Family-based interventions for improving self-management are effective for other chronic conditions, including for African Americans.
Evidence has demonstrated the unique and important role of family support in African Americans' hypertension management, and African Americans' preferences for the direct involvement of family in hypertension interventions.
The study team will develop a family-based hypertension self-management intervention ("Walk Together") for African Americans with uncontrolled hypertension that integrates community-based participatory perspectives in the specifics of the intervention.
The study team will pilot trial the culturally-adapted intervention in a primary care setting in order to examine the feasibility and acceptability of the Walk Together protocol.
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sarah B Woods, PhD
- Phone Number: 214-648-6225
- Email: Sarah.Woods@UTsouthwestern.edu
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75231
- Recruiting
- UT Southwestern Family Medicine Clinic at Texas Health Dallas
-
Contact:
- Manager of Clinical Operations
- Phone Number: 214-891-6400
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Black or African American
- Age 18 to 75
- Two blood pressure values ≥ 130/ ≥ 80 in 12 months prior
- Available family support person to join the intervention who agrees to participate
- English-speaking
Exclusion Criteria:
- Family support person is under the age of 18
- Documented cognitive impairment in patient's medical record
- Presence of severe psychiatric condition (i.e., current psychotic disorder or suicidality)
- Participation in prior hypertension health education intervention
- Prior participation in formative study activities (i.e., study focus groups)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Walk Together
Walk Together involves four sessions delivered in patients' primary care clinic over approximately two months.
Sessions are dyadic (i.e., all sessions include the patient and a family support person), last 30-90 minutes, and are delivered by a trained family therapist.
The intervention is a culturally-response, family-based intervention that is strengths-based and includes components of integrative behavioral couples therapy and motivational interviewing.
The goals of the intervention are to (a) optimize family support and communication, (b) improve hypertension knowledge, (c) enhance self-management goal-setting, and (d) increase shared problem-solving to address self-management adherence barriers.
Environmental barriers to adherence are also addressed consistent with standard care.
|
Receive training in the use of a study-provided blood pressure cuff and hypertension education; engage in hypertension self-management goal-setting; identify barriers to self-management adherence and utilize shared problem-solving to address barriers; connect to existing clinic resources to address environmental barriers; promote relationship strengths; practice communication and behavioral skills to address relationship concerns; engage family in support of patient self-management goals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of intervention as measured by the number of participants accrued
Time Frame: 11 months
|
Feasibility of intervention is measured by the number of participants accrued or consented and ready to participate to meet the recruitment goal of 30 dyads
|
11 months
|
Feasibility of intervention as measured by the rate of refusal among eligible patients/family members
Time Frame: 11 months
|
Feasibility of intervention is measured by the rate of refusal among eligible patients/family members which is the number of participants refusing to consent
|
11 months
|
Adherence to the intervention as measured by the proportion of dyads successfully completing the four intervention components
Time Frame: 11 months
|
Adherence to the intervention as measured by the proportion of dyads successfully completing the four intervention components
|
11 months
|
Adherence to the intervention as measured by the proportion of participants completing post-treatment assessments
Time Frame: 11 months
|
Adherence to the intervention as measured by the proportion of participants completing post-treatment assessment
|
11 months
|
Attrition as measured by the proportion of consented participants who dropped out of the entire study
Time Frame: 11 months
|
Attrition is defined as measured by the proportion of consented participants who dropped out of the entire study.
If the dropout rate is more than 20% then it will be considered as attrition
|
11 months
|
Acceptability of intervention as measured by 8-item Client Satisfaction Questionnaire
Time Frame: Protocol completion (approx. 24 months)
|
Acceptability of intervention is measured by 8-item Client Satisfaction Questionnaire.
Possible scores range from 8 to 32, with higher values indicating higher satisfaction
|
Protocol completion (approx. 24 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Family relationship quality as measured by the FACES-IV Short Form at Baseline
Time Frame: Baseline
|
Family relationship quality is measured by the Family Adaptability and Cohesion Scale IV (FACES-IV) Short Form.
Possible scores range from 1-5 where higher scores indicate better outcome.
|
Baseline
|
Family relationship quality as measured by the FACES-IV Short Form at following session 3
Time Frame: Following session 3 (Feedback Session, approx. 2-3 weeks after Baseline)
|
Family relationship quality is measured by the Family Adaptability and Cohesion Scale IV (FACES-IV) Short Form.
Possible scores range from 1-5 where higher scores indicate better outcome.
|
Following session 3 (Feedback Session, approx. 2-3 weeks after Baseline)
|
Family relationship quality as measured by the FACES-IV Short Form at following session 4
Time Frame: Following session 4 (Booster Check-in session, approx. 7-8 weeks after Baseline)
|
Family relationship quality is measured by the Family Adaptability and Cohesion Scale IV (FACES-IV) Short Form.
Possible scores range from 1-5 where higher scores indicate better outcome.
|
Following session 4 (Booster Check-in session, approx. 7-8 weeks after Baseline)
|
Family relationship quality as measured by the Chronic Illness Resources Survey at Baseline
Time Frame: Baseline
|
Family relationship quality is measured by the Chronic Illness Resources Survey.
Possible scores range from 1-5 where higher scores indicate better outcome.
|
Baseline
|
Family relationship quality as measured by the Chronic Illness Resources Survey following session 3
Time Frame: Following session 3 (Feedback Session, approx. 2-3 weeks after Baseline)
|
Family relationship quality is measured by the Chronic Illness Resources Survey.
Possible scores range from 1-5 where higher scores indicate better outcome.
|
Following session 3 (Feedback Session, approx. 2-3 weeks after Baseline)
|
Family relationship quality as measured by the Chronic Illness Resources Survey following session 4
Time Frame: Following session 4 (Booster Check-in session, approx. 7-8 weeks after Baseline)
|
Family relationship quality is measured by the Chronic Illness Resources Survey.
Possible scores range from 1-5 where higher scores indicate better outcome.
|
Following session 4 (Booster Check-in session, approx. 7-8 weeks after Baseline)
|
Health knowledge as measured by the Hypertension (HTN) Evaluation of Lifestyle and Management Knowledge scale at Baseline
Time Frame: Baseline
|
Health knowledge is measured by the HTN Evaluation of Lifestyle and Management Knowledge scale.
Possible scores range from 0-14 where higher scores indicate better health knowledge.
|
Baseline
|
Health knowledge as measured by the Hypertension (HTN) Evaluation of Lifestyle and Management Knowledge scale following session 3
Time Frame: Following session 3 (Feedback Session, approx. 2-3 weeks after Baseline)
|
Health knowledge is measured by the HTN Evaluation of Lifestyle and Management Knowledge scale.
Possible scores range from 0-14 where higher scores indicate better health knowledge.
|
Following session 3 (Feedback Session, approx. 2-3 weeks after Baseline)
|
Health knowledge as measured by the Hypertension (HTN) Evaluation of Lifestyle and Management Knowledge scale following session 4
Time Frame: Following session 4 (Booster Check-in session, approx. 7-8 weeks after Baseline)
|
Health knowledge is measured by the HTN Evaluation of Lifestyle and Management Knowledge scale.
Possible scores range from 0-14 where higher scores indicate better health knowledge.
|
Following session 4 (Booster Check-in session, approx. 7-8 weeks after Baseline)
|
HTN self-management as measured by the HTN Self-Care Activity Level Effects measure at Baseline
Time Frame: Baseline
|
HTN self-management is measured by the HTN Self-Care Activity Level Effects measure.
The Hypertension Self-Care Activity Level Effects (H-SCALE) questionnaire assesses adherence to hypertension medication (possible subscale scores range from 0-21), physical activity engagement (possible subscale scores range from 0-14), eating a healthy diet (possible subscale scores range from 0-77), alcohol intake (possible subscale scores range from 0-1), tobacco exposure (possible subscale scores range from 0-14), and weight management (possible subscale scores range from 10-50).
Possible cumulative adherence (index) scores range from 0-6 where higher scores indicate better adherence.
|
Baseline
|
HTN self-management as measured by the HTN Self-Care Activity Level Effects measure at Baseline
Time Frame: Following session 3 (Feedback Session, approx. 2-3 weeks after Baseline)
|
HTN self-management is measured by the HTN Self-Care Activity Level Effects measure.
The Hypertension Self-Care Activity Level Effects (H-SCALE) questionnaire assesses adherence to hypertension medication (possible subscale scores range from 0-21), physical activity engagement (possible subscale scores range from 0-14), eating a healthy diet (possible subscale scores range from 0-77), alcohol intake (possible subscale scores range from 0-1), tobacco exposure (possible subscale scores range from 0-14), and weight management (possible subscale scores range from 10-50).
Possible cumulative adherence (index) scores range from 0-6 where higher scores indicate better adherence.
|
Following session 3 (Feedback Session, approx. 2-3 weeks after Baseline)
|
HTN self-management as measured by the HTN Self-Care Activity Level Effects measure at Baseline
Time Frame: Following session 4 (Booster Check-in session, approx. 7-8 weeks after Baseline)
|
HTN self-management is measured by the HTN Self-Care Activity Level Effects measure.
The Hypertension Self-Care Activity Level Effects (H-SCALE) questionnaire assesses adherence to hypertension medication (possible subscale scores range from 0-21), physical activity engagement (possible subscale scores range from 0-14), eating a healthy diet (possible subscale scores range from 0-77), alcohol intake (possible subscale scores range from 0-1), tobacco exposure (possible subscale scores range from 0-14), and weight management (possible subscale scores range from 10-50).
Possible cumulative adherence (index) scores range from 0-6 where higher scores indicate better adherence.
|
Following session 4 (Booster Check-in session, approx. 7-8 weeks after Baseline)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sarah Woods, PhD, UT Southwestern Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 5, 2024
Primary Completion (Estimated)
February 3, 2025
Study Completion (Estimated)
March 31, 2025
Study Registration Dates
First Submitted
October 13, 2022
First Submitted That Met QC Criteria
January 2, 2023
First Posted (Actual)
January 4, 2023
Study Record Updates
Last Update Posted (Actual)
April 9, 2024
Last Update Submitted That Met QC Criteria
April 5, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU-2022-0568
- R21MD017658-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
Clinical Trials on Walk Together
-
York UniversityMcMaster University; University of TorontoCompletedFamily Conflict | Internet-Based InterventionCanada
-
York UniversityMcMaster University; University of TorontoActive, not recruitingMarital Relationship | Family Conflict | Internet-Based Intervention | Interparental Conflict | Marital ConflictCanada
-
University of ConnecticutNational Heart, Lung, and Blood Institute (NHLBI); Worcester Polytechnic InstituteCompleted
-
Barretos Cancer HospitalUnknown
-
University of British ColumbiaPublic Health Agency of Canada (PHAC); The Bridge Youth and Family Services...CompletedOverweight and Obesity | Health Knowledge, Attitudes, PracticeCanada
-
Caroline RowlandCompletedLanguage DevelopmentUnited Kingdom
-
University of MinnesotaNot yet recruiting
-
University of California, San FranciscoUniversity of California, BerkeleyCompleted
-
University of MinnesotaCompletedStress | AttentionUnited States
-
Joslin Diabetes CenterTerminatedDiabetes | Physical ActivityUnited States